U.S. Physical Therapy's 15min Chart Indicates Bearish Marubozu with Narrowing Bollinger Bands.

Based on the technical analysis of U.S. Physical Therapy's 15-minute chart, a narrowing of Bollinger Bands, coupled with a bearish Marubozu at 09/03/2025 14:00, indicates a reduction in the magnitude of stock price fluctuations, suggesting that sellers are currently dominating the market. This bearish momentum is likely to persist in the near term.

Investors seeking value in the Medical - Outpatient and Home Healthcare sector are likely considering Astrana Health, Inc. (ASTH) and U.S. Physical Therapy (USPH). To determine which stock presents a better value opportunity, we analyze both companies using Zacks Rank and Style Scores, along with key valuation metrics.

Astrana Health, Inc. (ASTH) and U.S. Physical Therapy (USPH) currently hold Zacks Ranks of #1 (Strong Buy) and #3 (Hold), respectively. ASTH's stronger earnings outlook is evident from its Zacks Rank. However, value investors also consider traditional valuation metrics such as the P/E ratio, P/S ratio, earnings yield, cash flow per share, and the PEG ratio.

ASTH's forward P/E ratio stands at 23.09 compared to USPH's 31.71. The PEG ratio, which considers the stock's expected earnings growth rate, is 0.78 for ASTH versus 4.15 for USPH. Additionally, ASTH's P/B ratio is 2.28, while USPH's is 2.5. These metrics contribute to ASTH's Value grade of B and USPH's Value grade of C.

Moreover, a technical analysis of USPH's 15-minute chart reveals a narrowing of Bollinger Bands and a bearish Marubozu at 09/03/2025 14:00, indicating reduced price fluctuations and seller dominance. This bearish momentum is likely to persist in the near term.

In conclusion, based on both fundamental and technical analysis, Astrana Health, Inc. (ASTH) appears to be the better value option compared to U.S. Physical Therapy (USPH) at this time.

References:
[1] https://www.nasdaq.com/articles/asth-vs-usph-which-stock-better-value-option